Jazz Pharmaceuticals
JAZZ
JAZZ
295 hedge funds and large institutions have $5.68B invested in Jazz Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 93 increasing their positions, 118 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 118
35% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 72
37% less call options, than puts
Call options by funds: $41.4M | Put options by funds: $65.5M
Holders
295
Holding in Top 10
9
Calls
$41.4M
Puts
$65.5M
Top Buyers
| 1 | +$83M | |
| 2 | +$70.4M | |
| 3 | +$51.8M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.3M |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$32.5M |
Top Sellers
| 1 | -$141M | |
| 2 | -$89.6M | |
| 3 | -$62.6M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$41.3M |
| 5 |
Goldman Sachs
New York
|
-$36.2M |